Skip to content

Comparison of the effect of Fentanyl and Sufentanil added to Bupivacaine on post-cesarean pain.

Comparison of the effect of Fentanyl and Sufentanil added to intrathecal Bupivacaine on post operative pain after elective cesarean section in pregnant women

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016101530303N1
Enrollment
90
Registered
2017-03-21
Start date
2016-10-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain after cesarean section. Delivery

Interventions

Intervention 1: Intervention group 1: 10 mg of 0.5% bupivacaine with 25 micrograms of fentanyl prescribed intrathecally into cerebrospinal fluid, at the space between the vertebrae 4 and 5 lumbar in t
Treatment - Drugs
Intervention group 1: 10 mg of 0.5% bupivacaine with 25 micrograms of fentanyl prescribed intrathecally into cerebrospinal fluid, at the space between the vertebrae 4 and 5 lumbar in the midline, usin
Intervention group 2: 10 mg of 0.5% bupivacaine with 25 micrograms of sufentanil prescribed intrathecally into cerebrospinal fluid, at the space between the vertebrae 4 and 5 lumbar in the midline, us

Sponsors

Vice Chancellor for research of Hormozgan University of Medical Sciences, Bandar Abbas.
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
10 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: class ? or ? of ASA (American Society of Anesthesiologists; candidate for elective cesarean section; no history of heart disease, hypertension, preeclampsia, gestational diabetes; being satisfied to receive intrathecal anesthesia and participate in the study. Exclusion criteria: contraindication for spinal anesthesia; presence of infection in the needle insertion site; high intracranial pressure; coagulopathy; platelet count lower than 75000.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
The numbness. Timepoint: 3 times (every 8 hours) in the first 24 hours. Method of measurement: Questionnaire.;Blood Pressure. Timepoint: Monitoring during the first 24 hours. Method of measurement: Questionnaire.;Analgesia. Timepoint: 3 times (every 8 hours) in the first 24 hours. Method of measurement: Questionnaire.

Secondary

MeasureTime frame
Nausea and vomiting. Timepoint: 3 times (every 8 hours) in the first 24 hours. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbbas Pak Nahad

Anaesthesiology, Critical Care and Pain Management Research Center, Hormozgan University of Medical

apnabbas68@gmail.com+98 71 5344 2196

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026